Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design.INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
Company Details
- Employees
- 33
- Address
- Biodata Innovation Centre, Wellcome Genome Campus, Cambridge,cb10 1dr,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.brokenstringbio.com
- Keywords
- Technician jobs.
- HQ
- Cambridge
Broken String Biosciences Questions
Broken String Biosciences's website is http://www.brokenstringbio.com
Broken String Biosciences's LinkedIn profile is https://uk.linkedin.com/company/broken-string-biosciences-ltd
Broken String Biosciences has
33 employees.
View email and phone details for 33
employees at Broken String Biosciences.
Broken String Biosciences's industry is
Biotechnology Research
Broken String Biosciences's top competitors are
Quantum-Si,
Biotax,
Ultima Genomics,
Lifebit,
Qkine,
Adicet Bio, Inc,
Biomodal,
Mitra Bio,
Beacon Therapeutics,
Illumina Ventures.
Broken String Biosciences's categories are Biotechnology Research
